AMGN logo

Amgen Inc. (AMGN)

$379.42

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on AMGN

Market cap

$204.31B

EPS

14.23

P/E ratio

28.9

Price to sales

5.61

Dividend yield

2.657%

Beta

0.466454

Price on AMGN

Previous close

$374.75

Today's open

$375.26

Day's range

$374.74 - $381.78

52 week range

$261.43 - $385.12

Profile about AMGN

CEO

Robert A. Bradway

Employees

28000

Headquarters

Thousand Oaks, CA

Exchange

Nasdaq Global Select

Shares outstanding

538480671

Issue type

Common Stock

AMGN industries and sectors

Healthcare

Pharmaceuticals

News on AMGN

AMGEN TO PRESENT AT THE 46TH ANNUAL TD COWEN HEALTH CARE CONFERENCE

THOUSAND OAKS, Calif., Feb. 24, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 46th Annual TD Cowen Health Care Conference at 1:10 p.m.

news source

PRNewsWire • 3 hours ago

news preview

Why Amgen (AMGN) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

news source

Zacks Investment Research • Feb 23, 2026

news preview

Harbor Large Cap Value Fund Q4 2025 Portfolio Review

During the fourth quarter, the Harbor Large Cap Value Fund returned 1.26%, underperforming its benchmark, the Russell 1000® Value Index, which returned 3.81%, and underperforming the 2.66% return of the S&P 500 Index. The top five contributors to relative performance during the fourth quarter were: Parker Hannifin, Capital One Financial, Amgen, Merck, and Danaher. The bottom five detractors from relative performance were: Lennar, Uber, Sony, Microsoft, and Teledyne Technologies.

news source

Seeking Alpha • Feb 23, 2026

news preview

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

news source

Zacks Investment Research • Feb 20, 2026

news preview

Amgen Inc. (AMGN) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript

Amgen Inc. (AMGN) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript

news source

Seeking Alpha • Feb 18, 2026

news preview

AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT

THOUSAND OAKS, Calif., Feb. 13, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2026 Virtual Oncology Leadership Summit at 12:15 p.m.

news source

PRNewsWire • Feb 13, 2026

news preview

Prices, pipelines and patent cliffs: Inside pharma's big reset

Pharma earnings weren't the main focus for drugmakers this quarter. "2025 was about understanding kind of the rules of the future of the game," McKinsey Senior Partner Greg Graves told CNBC.

news source

CNBC • Feb 13, 2026

news preview

Amgen Inc. (AMGN) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript

Amgen Inc. (AMGN) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript

news source

Seeking Alpha • Feb 13, 2026

news preview

These 32 favorite stocks signal the bull market is running on fumes

The S&P 500 sectors that top investment newsletters currently like most are strongest at market peaks.

news source

Market Watch • Feb 12, 2026

news preview

Amgen (AMGN) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

news source

Zacks Investment Research • Feb 11, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Amgen Inc.

Open an M1 investment account to buy and sell Amgen Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in AMGN on M1